^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Multiple Myeloma |
| Drug: | Venclexta (venetoclax) (Bcl2 inhibitor) + dexamethasone (GCR agonist) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Multiple Myeloma: Useful In Certain Circumstances…Venetoclax/dexamethasone only for t(11;14) patients
